CoagulationDisorders near Scranton, PA

Biography: Dr. Leon Smith, MD is a Maternal-Fetal Medicine Specialist who practices in Livingston, NJ. He is 66 years old. Dr. Leon Smith, MD is affiliated with Cooperman Barnabas Medical Center.

Biography: Dr. Salvatore Caruana is the Director of the Division of Head and Neck Surgery in the Department of Otolaryngology-Head and Neck Surgery at NewYork-Presbyterian Hospital Columbia University Medical Center. He is a widely respected head and neck surgeon in the forefront of the surgical treatment of tumors of the mouth pharynx, larynx and sinuses, parathyroid surgery, thyroid gland, and salivary glands. He is a pioneer in laser microsurgery for pharyngeal and laryngeal cancers. Dr. Caruana is an Associate Clinical Professor of Otolaryngology and Head and Neck Surgery at the Columbia University College of Physicians and Surgeons. Dr. Caruana graduated cum laude from the University of Buffalo and completed his Doctor of Medicine at Mount Sinai School of Medicine. His general surgery training at St. Vincent's Hospital and Medical Center was followed by a residency in Otolaryngology at New York Eye and Ear Infirmary. He then completed an NIH funded two-and-a-half-year fellowship in Head and Neck Surgical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Caruana's peer-reviewed research has included work centering upon the biological nature of several head and neck cancers and on the role of viruses in malignancies of the paranasal sinuses.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Biography: Dr. Celina Ang, MD is a Hematology Specialist who practices in New York, NY. She is 46 years old. Dr. Celina Ang, MD is affiliated with Mount Sinai Hospital and Mount Sinai Morningside.

Care Philosophy: Our medical center provides an extraordinary opportunity to work with clinicians and scientists with expertise in all facets of HIV/AIDS and clotting disorders associated with small blood vessel injury such as TTP and aHUS. Working with them in the diagnosis and treatment of these diseases for over 25 years, I have developed a strong interest in HIV-related hematologic disorders as well as osteoporosis and other metabolic complications arising during antiretroviral therapy for HIV.

Biography: Michal Bar-Natan, MD, is Interim Assistant Professor of Medicine and a member of the Leukemia Program at Weill Cornell Medicine and NewYork-Presbyterian Hospital in New York City.Dr. Bar-Natan graduated cum laude from the Sackler School of Medicine. She completed her Internal Medicine Residency at Sheba Medical Center and her Fellowship in Hematology and Medical Oncology at NYU Langone Health.In addition to her clinical fellowship training, Dr. Bar-Natan completed a research fellowship at Dana Farber Cancer Institute and Brigham and Women's Hospital (Harvard Medical School) with a focus on the role that signal transducer and activator of transcription (STAT) proteins play in the development and treatment of myeloproliferative neoplasms (MPNs) and leukemias.Prior to this position Dr. Bar-Natan served as Associate Professor of Medicine at the Icahn School of Medicine at Mt. Sinai, an Attending Physician with the Center of Excellence for Blood Cancers and Myeloid Disorders, and as the leader of the Acute Lymphoblastic Leukemia programat the Mt. Sinai Tisch Cancer Institute.Dr. Bar-Natan's focus is on translational research in malignant hematology, particularly myeloid malignancies and acute lymphoblastic leukemia, and the development of investigator-initiated clinical trials for patients with these conditions. She leads early phase clinical trials implementing new therapeutic approaches, such as immunotherapies and combination therapies, and serves as the PI and co-investigator on many clinical trials for acute leukemias and myeloproliferative neoplasms.

Care Philosophy: Pancreatic cancer has been my area of clinical and research focus for the past 15 years. I participated in the process of recognition that outcomes of complex surgery such as that for pancreatic cancer are better in high volume centers when performed by experienced surgeons. In 2006, I conceived, funded and built a multidisciplinary unit with the mission of improving overall outcomes in pancreatic cancer care by integrating the care of multiple medical specialists.